A high level of clinical response is associated with improved patient-reported outcomes in psoriasis: Analyses from a phase 2 study in patients treated with ixekizumab

E. Edson-Heredia, S. Banerjee, B. Zhu, T. Maeda-Chubachi, G. S. Cameron, W. Shen, M. P. Heffernan, K. B. Gordon, C. L. Leonardi*

*Corresponding author for this work

Research output: Contribution to journalLetter

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)864-865
Number of pages2
JournalJournal of the European Academy of Dermatology and Venereology
Volume30
Issue number5
DOIs
StatePublished - May 1 2016

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this